Skip to Content

MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)

Generic Name: acrivastine/pseudoephedrine

Pill with imprint MEDEVA SEMPREX-D is Green & White, Capsule-shape and has been identified as Semprex-D 8 mg-60 mg. It is supplied by Celltech Pharmaceuticals Inc..

Semprex-D is used in the treatment of allergic rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy. Semprex-D 8 mg-60 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MEDEVA SEMPREX-D

Semprex-D 8 mg-60 mg MEDEVA SEMPREX-D

Semprex-D

Generic Name
acrivastine/pseudoephedrine
Imprint
MEDEVA SEMPREX-D
Strength
8 mg-60 mg
Color
Green & White
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Upper respiratory combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celltech Pharmaceuticals Inc.
National Drug Code (NDC)
53014-0404

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.